Related Experiment Video

Updated: Aug 28, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.9K

Impact of COVID-19 in Children with Chronic Lung Diseases

Valentina Agnese Ferraro1, Stefania Zanconato1, Silvia Carraro1

  • 1Unit of Pediatric Allergy and Respiratory Medicine, Women's and Children's Health Department, University of Padova, 35128 Padova, Italy.

International Journal of Environmental Research and Public Health
|September 23, 2022
PubMed

Insights

Children with chronic lung disease (CLD) face increased COVID-19 risks, but may also have protective factors. The pandemic

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has impacted global health.
  • Children with chronic lung diseases (CLD) may be at increased risk.
  • Understanding COVID-19's impact on this vulnerable pediatric population is crucial.

Purpose of the Study:

  • To review the impact of COVID-19 on children with CLD.
  • To analyze potential risk and protective factors in this population.
  • To examine the psychological effects of pandemic restrictions on affected children.

Main Methods:

  • A narrative review of existing literature.
  • Searched MEDLINE/PubMed for studies on COVID-19/SARS-CoV-2 and pediatric chronic lung diseases.
  • Included studies focused on children aged 0-18 years.

Main Results:

  • COVID-19 is typically mild in children, but CLD can be a risk factor if severe or poorly controlled.
  • Preventive measures and asthma management (inhaled corticosteroids, T2 inflammation) may offer protection.
  • Pandemic-related restrictions significantly impacted the psychological well-being of children with CLD.

Conclusions:

  • While CLD can increase COVID-19 severity in children, certain factors may mitigate risk.
  • The psychological impact of the pandemic on children with CLD requires attention.
  • Further research is needed to fully understand COVID-19's long-term effects on pediatric CLD.
Abstract

Keywords:
COVID-19SARS-CoV-2childrenchronic lung disease

More Related Videos

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

845
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
463
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K